PFSCF News and Press, Liminal Biosciences Inc - Ordinary Shares

LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, UK , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL)  ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs ...

LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in p...

Liminal BioSciences to Present at Stifel Healthcare Conference Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 15, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 15, 2019 /CNW Telbec/ - Liminal BioSciences Inc. (TS...

Liminal BioSciences to Commence Trading Common Shares on NASDAQ Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 15, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 15, 2019 /CNW Telbec/ - Liminal BioSciences Inc. (TSX: L...

/C O R R E C T I O N from Source -- Liminal BioSciences Inc./ Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 11, 2019 In the news release, Liminal BioSciences Reports its 2019 Third Quarter Financial Results and Business Highlights, issued 11-N...

The following slide deck was published by Liminal BioSciences Inc. in conjunction with their 2019 Q3 earnings Read more ...

Liminal BioSciences Inc. (PFSCF) Q3 2019 Earnings Conference Call November 13, 2019 8:30 AM ET Company Participants Murielle Lortie – Chief Financial Officer Ken Galbraith – Chief Executive Officer Conference Call Participants Derren Nathan – Hybridan ...

Liminal Biosciences Announces Key Appointment to its Leadership Team Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 13, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 13, 2019 /CNW Telbec/ - Liminal BioSciences In...

Liminal BioSciences Presents New Preclinical Data on PBI-4050 and NASH Candidate PBI-4547 Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 12, 2019 New preclinical data suggests PBI-4547 displays pleiotropic activities and has been shown to reduc...

Liminal BioSciences to Report Q3 2019 Results and Hold Conference Call Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 11, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 11, 2019 /CNW Telbec/ - Liminal BioSciences ...